(Urotoday.com) As part of a plenary presentation at the European Association of Urology (EAU) Virtual Annual Meeting assessing “Testis cancer and surgical andrology,” Dr. Andreas Hiester argued for the role of robotic-assisted retroperitoneal lymph node dissection (RPLND).